title: [Aspirin against aging? For whom and how much?].
abstract: Aspirin has been successfully used in the secondary prophylaxis of myocardial infarction, cerebral vascular events and peripheral arterial disease. Regular aspirin intake may further be beneficial in asymptomatic healthy male with cardiovascular risk factors over the age of 50. There is no good evidence that aspirin prevents the development of atherosclerosis and thromboembolic events in healthy individuals.
authors.affiliation: Departement für Innere Medizin, Universitätsspital Zürich.
authors.forename: O
authors.initials: O
authors.lastname: Oelz
authors.forename: P J
authors.initials: PJ
authors.lastname: Meier
mesh_terms: D001095:Arachidonic Acids / Q000037:antagonists & inhibitors*; D001241:Aspirin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000517:prevention & control*; D003327:Coronary Disease / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D008875:Middle Aged; D011322:Primary Prevention
chemical_list: D001095:Arachidonic Acids; D001241:Aspirin
vernacular_title: Aspirin gegen das Altern? Für wen und wieviel?